The Benefits of myPlan to Help Identify High-Risk Patients With NSCLC

November 24, 2016
Jeffrey Schneider, MD

Jeffrey Schneider, MD, chief of hematology and medical oncology, Winthrop University Hospital, discusses the benefits of Myriad's myPlan in determining high-risk patients with non-small cell lung cancer (NSCLC).